Pratélan Usada Pokok Modhèl WHO
Pratélan Usada Pokok Modhèl WHO (EML), dibabar déning World Health Organization (WHO), isiné usada-usada sing dianggep paling mempan tur aman tumrap kabutuhan paling ndhasari ing sistem kaséhatan. Pratélan iki asring dicakaké ing manéka nagara minangka dhasaran nalika nggawé pratélan usada pokok sing enggon-enggonan ing nagarané dhéwé-dhéwé.[1] Dhèk taun 2016, 155 nagara punjul wis nggawé pratélan usada pokok nasional sing dhedhasar pratélan modhèl World Health Organization iki.[2] Nagara-nagara sing ngecakaké kalebu nagara-nagara maju saha nagara-nagara tumuwuh.[1]
Pratélan iki dipérang dadi barang-barang inti lan barang-barang lelengkap. Éwoning barang-barang inti iku ingaran sing paling mujarab kanggo ngatasi masalah kaséhatan lan bisa dicakaké kanthi tambahan sumber daya layanan kaséhatan sing minimal. Éwadéné, éwoning barang-barang lelengkap mbutuhaké infrastruktur tambahan kaya ta juru awèh layanan kaséhatan sing digladhi mirunggan utawa piranti dhiagnostik utawa duwé rasio béya-bathi sing cilik.[3] Pratélan lelengkap nglimputi watara 25% barang ing pratélan iki.[4] Sawenèh usada kagolong becik ing pratélan inti uga ing pratélan lelengkap.[5] Sanadyan kèh-kèhé usada ing pratélan iku weton gènerik, ana ing pangayomané patèn ora ateges ngejabakaké inklusi.[6]
Pratélané pisanan dibabar taun 1977 lan macak usada cacah 212.[1][7] WHO banjur nganyari pratélané mbaka rong taun.[8] Pratélan sing kaping 14 dibabar taun 2005 lan macak usada cacah 306.[9] Ing taun 2015, èdhisi kaping 19 dibabar lan macak watara 410 usada.[8] Èdhisi kaping 20 dirancang babaré ing taun 2017. Pratélan-pratélan nasional macak watara 334 lan 580 usada.[4]
Pratélan sing ndhèwèki diyasa kanggo bocah umur tekan 12 taun, ingaran Pratélan Usada Pokok kanggo Bocah Modhèl WHO (EMLc). Pratélan iki diripta taun 2007 lan saiki wis nyadhak èdhisi kaping 5.[8][10] Pratélan iki digawé kanggo minangkani butuhé bocah kanthi cumepaké formulasi sing trep.[11][12] Samubarang sing ana ing pratélan kanggo bocah iku uga kapacak ing pratélan pokok.[13] Pratélan kanggo bocah dalah cathetané iku dhedhasar èdhisi kaping 19 pratélan pokok. Simbul α mratandhani yèn sawijining usada mung kapacak ing pratélan lelengkap.[3]
Anèstètik
[besut | besut sumber]Anèstètik umum lan oksigèn
[besut | besut sumber]Usada inhalasi
[besut | besut sumber]- Halotan
- Isofluran
- Oksidha nitro
- Oksigèn
Usada suntik
[besut | besut sumber]- Kétamin
- Propofol[cathetan 1]
Anèstètik enggon-enggonan
[besut | besut sumber]- Bupivakain
- Lidhokain
- Lidhokain/épinéfrin
- Éfédrinα (dudu anèstètik enggon-enggonan, kalebu ing pratélan iki awit kanggo panyegah wewesan getih sing asor sing gegayutan karo anèstèsi spinal nalika operasi sésar)
Usada praoperasi lan sédasi tumrap prosedhur kala-cendhak
[besut | besut sumber]- Atropin
- Midhazolam
- Morfin
Usada kanggo lara lan pangrumat paliatif
[besut | besut sumber]Nonopioid lan usada anti-inflamasi nonstéroid (NSAIDs)
[besut | besut sumber]
- Asem asètilsalisilat (aspirin)
- Ibuprofèn
- Parasétamol[cathetan 2] (asétaminofèn)
Analgèsik opioid
[besut | besut sumber]- Kodhéin
- Morfin[cathetan 3]
Usada tumrap tandha-tandha umum liyané babagan pangrumat paliatif
[besut | besut sumber]- Amitriptilin
- Siklizin
- Dhéksamétason
- Dhiazépam
- Sodhiyum dhokusat
- Fluoksètin
- Halopéridhol
- Butilbromid hioskin
- Hidrobromid hioskin
- Laktulos
- Lopéramid
- Métoklopramid
- Midhazolam
- Ondhansétron
- Sénna
Antialèrgi lan usada tumrap anafilaksis
[besut | besut sumber]- Dhéksamétason
- Épinéfrin (adrénalin)
- Hidrokortison
- Loratadhin[cathetan 4]
- Prédnisolon
Antidhot (panawa) lan dat liyané tumrap karacunan
[besut | besut sumber]Ora mirunggan
[besut | besut sumber]- Karbon aktif
Mirunggan
[besut | besut sumber]- Asétilsistéin
- Atropin
- Glukonat kalsiyum
- Klorid mètiltioninium (biru mètilèn)
- Nalokson
- Pénisilamin
- Biru prusia
- Nitrit sodhiyum
- Tiosulfat sodhium
- Dhéféroksaminα
- Dhimérsaprolα
- Fomépizolα
- Édhétat kalsiyum sodhiyumα
- Saksimerα
Usada antikonvulsi
[besut | besut sumber]- Karbamazépin
- Dhiazépam
- Lorazépam
- Sulfat magnésiyum[cathetan 5]
- Fénobarbital
- Fénitoin
- Asem valporat (valporat sodhiyum)
- Éthosuksimidα
Usada antiinfèksi
[besut | besut sumber]Antihèlmintik (obat cacing)
[besut | besut sumber]Antihèlmintik usus
[besut | besut sumber]
- Albèndhazol
- Lévamisol
- Mébéndhazol
- Niklosamid
- Prazikuwantèl
- Prantèl
Antifilarial
[besut | besut sumber]- Albéndhazol
- Dhiètilkarbamazin
- Ivèrmèktin
Antiskistosomal lan usada antinématod liyané
[besut | besut sumber]- Prazikuwantèl
- Triklabéndhazol
- Oksamnikuwinα
Antibiotik
[besut | besut sumber]Usada béta laktam
[besut | besut sumber]- Amoksisilin
- Amoksisilin/asem klavulan (amoksisilin + asem klavulan)
- Ampisilin
- Bènzilpénisilin bènzatin
- Bènzilpénisilin
- Séfalèksin
- Séfazolin[cathetan 6]
- Séfiksim[cathetan 7]
- Séftriakson[cathetan 8]
- Kloksasilin
- Fénoksimétilpénisilin (pénisilin V)
- Bènzilpénisilin prokain[cathetan 9]
- Séfotaksimα[cathetan 10]
- Sèftazidhimα
- Imipénèm/silastatinα[cathetan 11]
Antibaktèri liyané
[besut | besut sumber]- Azitromisin[cathetan 12]
- Kloramfénisol
- Siprofloksasin
- Klaritromisin[cathetan 13]
- Dhoksisiklin
- Èritromisin
- Géntamisin
- Métronidhazol
- Nitrofurantoin
- Spèktinomisin
- Trimétoprim/sulfamétoksazol
- Trimétoprim
- Slindhamisinα
- Vankomisinα
Usada antilèprosi
[besut | besut sumber]- Klofazimin
- Dhapson
- Rifampisin
Usada antituberkulosis
[besut | besut sumber]
- Étambutol
- Étambutol/isoniazid (étambutol + isoniazid)
- Étambutol/isoniazid/pirazinamid/rifampisin (étambutol + isoniazid + pirazinamid + rifampisin)
- Étambutol/isoniazid/rifampisin (étambutol + isoniazid + rifampisin)
- Isoniazid
- Isoniazid/pirazinamid/rifampisin (isoniazid + pirazinamid + rifampisin)
- Isoniazid/rifampicin (isoniazid + rifampisin)
- Pirazinamid
- Rifabutin[cathetan 14]
- Rifampisin
- Rifapèntin[cathetan 15]
- Amikasinα
- Bédhakuwilinα
- Kapréomisinα
- Siklosérinα[cathetan 16]
- Dhélamanidα
- Ètionamidα[cathetan 17]
- Kanamisinα
- Lévofloksasinα[cathetan 18]
- Linézolidα
- Asem p-aminosalisilikα
- Strèptomisinα
Usada antijamur
[besut | besut sumber]- Amfotérisin B
- Klotrimazol
- Flukonazol
- Flusitosin
- Griséofulvin
- Nistatin
- Iodid potasiyumα
Usada antivirus
[besut | besut sumber]Usada antihèrpes
[besut | besut sumber]- Asiklovir
Antirétrovirus
[besut | besut sumber]Inhibitor transkriptase balik nukléyosid/nukléyotid
[besut | besut sumber]- Abakavir (ABC)
- Lamivudhin (3TC)
- Stavudhin (d4T)
- Fumarat dhisoproksil ténofovir (TDF)
- Zidhovudhin (ZDV or AZT)
Inhibitor transkriptase balik non-nukléyosid
[besut | besut sumber]- Efavirenz (EGV or EFZ)
- Nevirapine (NVP)
Inhibitor protase
[besut | besut sumber]200mg.jpg)
- Atazanavir
- Darunavir
- Lopinavir/ritonavir (LPV/r)
- Ritonavir
- Saquinavir (SQV)
Gabungan dhosis ajeg
[besut | besut sumber]- Abacavir/lamivudine (abacavir + lamivudine)
- Efavirenz/emtricitabine/tenofovir[cathetan 19]
- Emtricitabine/tenofovir
- Lamivudine/nevirapine/stavudine
- Lamivudine/nevirapine/zidovudine
- Lamivudine/zidovudine
Antivirus liyané
[besut | besut sumber]- Osèltamivir[cathetan 20]
- Ribavirin[cathetan 21]
- Valgansiklovir
Usada antihépatitis
[besut | besut sumber]Usada tumrap hépatitis B
[besut | besut sumber]Inhibitor transkriptase walik nukléosid/nukléotid
- Èntekavir
- Fumarat dhisoproksil ténofovir (TDF)
Usada tumrap hépatitis C
[besut | besut sumber]Inhibitor polimérase nukléotid
- Sofosbuvir
Inhibitor protéase
- Simeprévir
Inhibitor NS5A
- Dhaklatasvir
Inhibitor polimérase non-nukléosid
- Dhasabuvir
Antivirus liyané
- Ribavirin[cathetan 22]
- Interféron-alfa-2a pégilasi utawa interféron-alfa-2b pégilasiα[cathetan 23]
Gabungan dhosis ajeg
- Lédhipasvir/sofosbuvir
- Ombitasvir/paritaprévir/ritonavir
Usada antiprotozoa
[besut | besut sumber]Usada antiamoéba lan antigiardhiasis
[besut | besut sumber]- Dhiloksanid
- Métronidhazol
Usada antiléismaniasis
[besut | besut sumber]- Amfotérisin B
- Miltéfosin
- Paromomisin
- Stiboglukonat sodhium utawa antimoniat méglumin
Usada antimalaria
[besut | besut sumber]Minangka tamba kuratif
[besut | besut sumber]- Amodiaquine[cathetan 24]
- Artemether[cathetan 25]
- Artemether/lumefantrine[cathetan 26]
- Artesunate[cathetan 27]
- Artesunate/amodiaquine[cathetan 28]
- Artesunate/mefloquine
- Chloroquine[cathetan 29]
- Doxycycline[cathetan 30]
- Mefloquine
- Primaquine[cathetan 31]
- Quinine[cathetan 32]
- Sulfadoxine/pyrimethamine[cathetan 33]
Kanggo panyegah
[besut | besut sumber]- Chloroquine[cathetan 34]
- Doxycycline
- Mefloquine
- Proguanil[cathetan 35]
Usada antipnéumosistosis lan antitoksoplasmosis
[besut | besut sumber]- Pyrimethamine
- Sulfadiazine
- Sulfamethoxazole/trimethoprim
- Pentamidineα
Usada antitripanosom
[besut | besut sumber]Tripanosomiasis afrika
[besut | besut sumber]Tataran angka 1
[besut | besut sumber]- Pentamidine[cathetan 36]
- Suramin sodium[cathetan 37]
Tataran angka 2
[besut | besut sumber]- Eflornithine[cathetan 38]
- Melarsoprol
- Nifurtimox[cathetan 39]
Tripanosomiasis amérika
[besut | besut sumber]- Benznidazole
- Nifurtimox
Usaga antimigrèn
[besut | besut sumber]Serangan akut
[besut | besut sumber]- Acetylsalicylic acid (Aspirin)
- Ibuprofen
- Paracetamol
Panyegah
[besut | besut sumber]- Propranolol
Antinéoplastik lan imunosuprèsif
[besut | besut sumber]Usada imunosuprèsif
[besut | besut sumber]Usada adjuvan lan sitotoksik
[besut | besut sumber]- All-trans retinoic acid (trétinoin)α
- Allopurinolα
- Asparaginaseα
- Bendamustineα
- Bleomycinα
- Calcium folinateα
- Capecitabineα
- Carboplatinα
- Chlorambucilα
- Cisplatinα
- Cyclophosphamideα
- Cytarabineα
- Dacarbazineα
- Dactinomycinα
- Daunorubicinα
- Docetaxelα
- Doxorubicinα
- Etoposideα
- Fludarabineα
- Fluorouracilα
- Filgrastimα
- Gemcitabineα
- Hydroxycarbamideα
- Ifosfamideα
- Imatinibα
- Irinotecanα
- Mercaptopurineα
- Mesnaα
- Methotrexateα
- Oxaliplatinα
- Paclitaxelα
- Procarbazineα
- Rituximabα
- Thioguanineα
- Trastuzumabα
- Vinblastineα
- Vincristineα
- Vinorelbineα
Hormon lan antihormon
[besut | besut sumber]- Anastrozoleα
- Bicalutamideα
- Dexamethasoneα
- Hydrocortisoneα
- Leuprorelinα
- Methylprednisoloneα
- Prednisoloneα
- Tamoxifenα
Usada antiparkinson
[besut | besut sumber]- Biperiden
- Carbidopa/levodopa (levodopa + carbidopa)
Usada sing mrabawani getih
[besut | besut sumber]Usada antianémia
[besut | besut sumber]- Ferrous salt
- Ferrous salt/folic acid
- Folic acid
- Hydroxocobalamin
Usada sing njalari koagulasi
[besut | besut sumber]- Enoxaparin
- Heparin sodium
- Phytomenadione
- Protamine sulfate
- Tranexamic acid
- Warfarin
- Desmopressinα
Usada liyané tumrap hémoglobinopati
[besut | besut sumber]- Deferoxamineα[cathetan 40]
- Hydroxycarbamideα
Wetoné getih lan gegantèn plasma sing asalé saka manungsa
[besut | besut sumber]Getih lan komponèn getih
[besut | besut sumber]
- Fresh frozen plasma
- Platelet concentrates
- Packed red blood cells
- Whole blood
Usada tumurun saka plasma
[besut | besut sumber]Imunoglobulin manungsa
[besut | besut sumber]- Rho(D) immune globulin
- Anti-rabies immunoglobulin
- Anti-tetanus immunoglobulin
- Human normal immunoglobulinα
Faktor koagulasi getih
[besut | besut sumber]Gantiné plasma
[besut | besut sumber]- Dextran 70[cathetan 41]
Usada kardhiovaskular
[besut | besut sumber]Usada antiangina
[besut | besut sumber]- Bisoprolol[cathetan 42]
- Glyceryl trinitrate
- Isosorbide dinitrate
- Verapamil
Usada antiaritmik
[besut | besut sumber]- Bisoprolol
- Digoxin
- Epinephrine (adrenaline)
- Lidocaine
- Verapamil
- Amiodaroneα
Usada antihipertènsi
[besut | besut sumber]- Amlodipine
- Bisoprolol
- Enalapril
- Hydralazine[cathetan 43]
- Hydrochlorothiazide
- Methyldopa[cathetan 44]
- Sodium nitroprussideα
Usada tumrap gagal jantung
[besut | besut sumber]- Bisoprolol
- Digoxin
- Enalapril
- Furosemide
- Hydrochlorothiazide
- Spironolactone
- Dopamineα
Usada antitrombotik
[besut | besut sumber]Usada antiplatelèt
[besut | besut sumber]- Acetylsalicylic acid (aspirin)
- Clopidogrel
Usada trombolitik
[besut | besut sumber]- Streptokinaseα
Agèn pangasor lipid
[besut | besut sumber]- Simvastatin[cathetan 45]
Dhèrmatologis (topikal)
[besut | besut sumber]Usada antijamur
[besut | besut sumber]- Miconazole
- Selenium sulfide
- Sodium thiosulfate
- Terbinafine
Usada antiinfèksi
[besut | besut sumber]- Mupirocin
- Potassium permanganate
- Silver sulfadiazine
Usada antiinflamasi lan antipruritik
[besut | besut sumber]- Betamethasone
- Calamine
- Hydrocortisone
Usada sing mrabawani diferensiasi lan proliferasi kulit
[besut | besut sumber]- Benzoyl peroxide
- Coal tar
- Fluorouracil
- Podophyllum resin
- Salicylic acid
- Urea
Skabisid lan pédikulisid
[besut | besut sumber]- Benzyl benzoate
- Permethrin
Agèn dhiagnostik
[besut | besut sumber]Usada optalmik
[besut | besut sumber]- Fluorescein
- Tropicamide
Médhia radhiokontras
[besut | besut sumber]- Amidotrizoate
- Barium sulfate
- Iohexol
- Meglumine iotroxateα
Dhisinfèktan lan antisèptik
[besut | besut sumber]Antisèptik
[besut | besut sumber]- Chlorhexidine
- Ethanol
- Povidone iodine
Dhisinfèktan
[besut | besut sumber]- Alcohol based hand rub
- Chlorine base compound
- Chloroxylenol
- Glutaral
Dhiurètik
[besut | besut sumber]- Amiloride
- Furosemide
- Hydrochlorothiazide
- Mannitol
- Spironolactone
Usada gastrointèstinal
[besut | besut sumber]- Pancreatic enzymesα
Usada antiulkus
[besut | besut sumber]- Omeprazole
- Ranitidine
Usada antimutah
[besut | besut sumber]- Dexamethasone
- Metoclopramide
- Ondansetron
Usada antiinflamasi
[besut | besut sumber]- Sulfasalazine
- Hydrocortisoneα
Laksatif
[besut | besut sumber]- Senna
Usada tumrap dhiaré
[besut | besut sumber]Réhidrasi oral
[besut | besut sumber]- Oral rehydration salts
Usada tumrap dhiaré ing bocah
[besut | besut sumber]- Zinc sulfate[cathetan 46]
Hormon, usada éndhokrin liyané, lan kontrasèpsi
[besut | besut sumber]Hormon adrénal lan gegantèn sintètik
[besut | besut sumber]- Fludrocortisone
- Hydrocortisone
Androgèn
[besut | besut sumber]- Testosteroneα
Kontrasèpsi
[besut | besut sumber]Kontrasèpsi hormonal oral
[besut | besut sumber]- Ethinylestradiol/levonorgestrel
- Ethinylestradiol/norethisterone
- Levonorgestrel
Kontrasèpsi hormonal suntik
[besut | besut sumber]- Estradiol cypionate/medroxyprogesterone acetate
- Medroxyprogesterone acetate
- Norethisterone enantate
Piranti intrauterus
[besut | besut sumber]- IUD with copper
- IUD with progestogen
Metodhe palang
[besut | besut sumber]- Condoms
- Diaphragms
Kontrasèpsi implan
[besut | besut sumber]- Etonogestrel—releasing implant
- Levonorgestrel—releasing implant
Kontrasèpsi intravagina
[besut | besut sumber]- Progesterone vaginal ring
Insulin lan usada liyané tumrap dhiabètes
[besut | besut sumber]- Gliclazide[cathetan 47]
- Glucagon
- Insulin injection (soluble)
- Intermediate-acting insulin
- Metformin
Indhuser ovulasi
[besut | besut sumber]- Clomifeneα
Progèstogèn
[besut | besut sumber]- Medroxyprogesterone acetate
Hormon tiroid lan usada antitiroid
[besut | besut sumber]- Levothyroxine
- Potassium iodide
- Propylthiouracil
- Lugol's solutionα
Usada imunologi
[besut | besut sumber]Agèn dhiagnostik
[besut | besut sumber]- Tuberculin, purified protéin derivative (PPD)
Séra lan usada imunoglobulin
[besut | besut sumber]- Antivenom immunoglobulin[cathetan 48]
- Diphtheria antitoxin
Vaksin
[besut | besut sumber]
- BCG vaccine
- Cholera vaccine[cathetan 49]
- Diphtheria vaccine
- Haemophilus influenzae type b vaccine
- Hepatitis A vaccine
- Hepatitis B vaccine
- HPV vaccine
- Influenza vaccine
- Japanese encephalitis vaccine[cathetan 50]
- Measles vaccine
- Meningococcal meningitis vaccine
- Mumps vaccine
- Pertussis vaccine
- Pneumococcal vaccine
- Poliomyelitis vaccine
- Rabies vaccine
- Rotavirus vaccine
- Rubella vaccine
- Tetanus vaccine
- Tick-borne encephalitis vaccine
- Typhoid vaccine
- Varicella vaccine
- Yellow fever vaccine
Panglemes otot (tumindak pèrifèr) lan kolinèstérase
[besut | besut sumber]- Atracurium
- Neostigmine
- Suxamethonium
- Vecuronium
- Pyridostigmineα
Pangupakara nétra
[besut | besut sumber]Agèn antiinfèksi
[besut | besut sumber]- Aciclovir
- Azithromycin
- Gentamicin
- Ofloxacin
- Tetracycline
Agèn antiinflamasi
[besut | besut sumber]- Prednisolone
Anèstètik enggon-enggonan
[besut | besut sumber]- Tetracaine
Usada miotik lan antiglaukoma
[besut | besut sumber]- Acetazolamide
- Latanoprost
- Pilocarpine
- Timolol
Usada midriatik
[besut | besut sumber]- Atropine[cathetan 51]
- Epinephrine (adrenaline)α
Faktor tuwuhé éndhotélial antivaskular (VEGF)
[besut | besut sumber]- Bevacizumabα
Usada oksitosik lan antioksitosik
[besut | besut sumber]Usada oksitosik lan abortifasièn
[besut | besut sumber]- Ergometrine
- Misoprostol
- Oxytocin
- Mifepristone used with misoprostolα[cathetan 52]
Usada antioksitosik (tokolitik)
[besut | besut sumber]- Nifedipine
Solusi dhialisis péritonéal
[besut | besut sumber]- Intraperitoneal dialysis solution (of appropriate composition)α
Usada tumrap gangguan pikir lan patrap
[besut | besut sumber]Usada tumrap gangguan psikotik
[besut | besut sumber]- Chlorpromazine
- Fluphenazine
- Haloperidol
- Risperidone
- Clozapineα
Usada tumrap gangguan swasana ati
[besut | besut sumber]Usada tumrap gangguan dhéprèsif
[besut | besut sumber]- Amitriptyline
- Fluoxetine
Usada tumrap gangguan bipolar
[besut | besut sumber]- Carbamazepine
- Lithium
- Valproic acid (sodium valproate)
Usada tumrap gangguan pangrudatin
[besut | besut sumber]- Diazepam
Usada tumrap gangguan obsèsif kompulsif
[besut | besut sumber]- Clomipramine
Usada tumrap gangguan amarga panganggoné dat psikoaktif
[besut | besut sumber]- Nicotine replacement therapy
- Methadoneα
Usada sing tumindak ing saluran ambegan
[besut | besut sumber]Antiasma lan usada tumrap lelara paru-paru obstuktif kronik
[besut | besut sumber]- Beclometasone
- Budesonide
- Epinephrine (adrenaline)
- Ipratropium bromide
- Salbutamol (albuterol)
Larudan kanggo ndandani gangguan banyu, èlèktrolit, lan asem-basa
[besut | besut sumber]Oral
[besut | besut sumber]- Oral rehydration salts
- Potassium chloride
Parèntéral
[besut | besut sumber]- Glucose
- Glucose with sodium chloride
- Potassium chloride
- Sodium chloride
- Sodium hydrogen carbonate
- Sodium lactate, compound solution
Liya-liyané
[besut | besut sumber]- Water for injection
Vitamin lan mineral
[besut | besut sumber]- Ascorbic acid
- Calcium
- Cholecalciferol[cathetan 53]
- Ergocalciferol
- Iodine
- Nicotinamide
- Pyridoxine
- Retinol
- Riboflavin
- Sodium fluoride
- Thiamine
- Calcium gluconateα
Usada kuping, irung, lan telak tumrap bocah
[besut | besut sumber]- Acetic acid
- Budesonide
- Ciprofloxacin
- Xylometazoline
Usada mirunggan tumrap pangrumat néonatal
[besut | besut sumber]Usada kawènèhaké marang néonatus
[besut | besut sumber]- Caffeine citrate
- Chlorhexidine
- Ibuprofenα
- Prostaglandin Eα
- Prostaglandin E1
- Prostaglandin E2
- Surfactantα
Usada kawènèhaé marang ibu
[besut | besut sumber]- Dexamethasone
Usada tumrap lelara gegelan
[besut | besut sumber]Usada tumrap éncok
[besut | besut sumber]Agèn modhifikasi lelara ing gangguan réumatoid
[besut | besut sumber]Lelara gegelan ing bocah enom
[besut | besut sumber]- Aspirin[cathetan 54]
Cathetan
[besut | besut sumber]- ^ An α indicates the medicine is only on the complementary list. For these items specialized diagnostic or monitoring or specialist training are needed. An item may also be listed as complementary on the basis of higher costs or a less attractive cost-benefit ratio.[3]
- ↑ Thiopental may be used as an alternative depending on local availability and cost.
- ↑ Not recommended for anti‐inflammatory use due to lack of proven benefit to that effect
- ↑ Alternatives limited to hydromorphone and oxycodone
- ↑ There may be a role for sedating antihistamines for limited indications (EMLc).
- ↑ For use in eclampsia and severe pre‐eclampsia and not for other convulsant disorders
- ↑ For surgical prophylaxis
- ↑ Only listed for single‐dose treatment of uncomplicated ano‐genital gonorrhoea
- ↑ Do not administer with calcium and avoid in infants with hyperbilirubinemia.
- ↑ Procaine benzylpenicillin is not recommended as first-line treatment for neonatal sepsis except in settings with high neonatal mortality, when given by trained health workers in cases where hospital care is not achievable.
- ↑ Third generation cephalosporin of choice for use in hospitalized neonates
- ↑ Only listed for the treatment of life‐threatening hospital‐based infection due to suspected or proven multidrug‐resistant infection
- ↑ Only listed for single‐dose treatment of genital Chlamydia trachomatis and of trachoma
- ↑ For use in combination regimens for eradication of H. pylori in adults
- ↑ For use only in patients with HIV receiving protease inhibitors
- ↑ For treatment of latent TB infection (LTBI) only
- ↑ Terizidone may be an alternative.
- ↑ Prothionamide may be an alternative.
- ↑ Ofloxacin and moxifloxacin may be alternatives based on availability and programme considerations.
- ↑ FTC is an acceptable alternative to 3TC, based on knowledge of the pharmacology, the resistance patterns and clinical trials of antiretrovirals.
- ↑ Potentially severe or complicated illness due to confirmed or suspected influenza virus infection in accordance with WHO treatment guidelines
- ↑ For the treatment of viral haemorrhagic fevers and in combination with pegylated interferons for the treatment of Hepatitis C
- ↑ For the treatment of hepatitis C, in combination with peginterferon or direct acting anti-viral medicines
- ↑ To be used in combination with ribavirin
- ↑ To be used in combination with artesunate 50 mg
- ↑ For use in the management of severe malaria
- ↑ Not recommended in the first trimester of pregnancy or in children below 5 kg
- ↑ To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine
- ↑ Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives.
- ↑ For use only for the treatment of P.vivax infection
- ↑ For use only in combination with quinine
- ↑ Only for use to achieve radical cure of P.vivax and P.ovale infections, given for 14 days
- ↑ For use only in the management of severe malaria, and should be used in combination with doxycycline
- ↑ Only in combination with artesunate 50 mg
- ↑ For use only in central American regions, for use for P.vivax
- ↑ For use only in combination with chloroquine
- ↑ To be used for the treatment of Trypanosoma brucei gambiense infection
- ↑ To be used for the treatment of the initial phase of Trypanosoma brucei rhodesiense infection
- ↑ To be used for the treatment of Trypanosoma brucei gambiense infection
- ↑ Only to be used in combination with eflornithine, for the treatment of T. b. gambiense infection
- ↑ Deferasirox oral form may be an alternative, depending on cost and availability.
- ↑ Polygeline, injectable solution, 3.5% is considered as equivalent.
- ↑ Includes metoprolol and carvedilol as alternatives
- ↑ Hydralazine is listed for use in the acute management of severe pregnancy‐induced hypertension only.
- ↑ Methyldopa is listed for use in the management of pregnancy‐induced hypertension only.
- ↑ For use in high‐risk patients
- ↑ In acute diarrhoea, zinc sulfate should be used as an adjunct to oral rehydration salts
- ↑ Glibenclamide not suitable above 60 years
- ↑ Exact type to be defined locally
- ↑ Recommended for some high-risk populations
- ↑ Recommended for certain regions
- ↑ Or homatropine (hydrobromide) or cyclopentolate (hydrochloride)
- ↑ Requires close medical supervision
- ↑ Ergocalciferol can be used as an alternative.
- ↑ For use for rheumatic fever, juvenile arthritis, Kawasaki disease
Rujukan
[besut | besut sumber]- ↑ a b c "Essential medicines". World Health Organization. Dibukak ing 19 Januari 2017.
- ↑ "The WHO Essential Medicines List (EML): 30th anniversary". World Health Organization. Dibukak ing 26 Juni 2016.
- ↑ a b c "19th WHO Model List of Essential Medicines" (pdf). who.int. World Health Organization. April 2015. kc. Annex 1. Dibukak ing 17 Januari 2017.
- ↑ a b Bansal, D; Purohit, VK (January 2013). "Accessibility and use of essential medicines in health care: Current progress and challenges in India". Journal of Pharmacology & Pharmacotherapeutics. 4 (1): 13–8. doi:10.4103/0976-500X.107642. PMC 3643337. PMID 23662019.
- ↑ "The Selection and Use of Essential Medicines - WHO Technical Report Series, No. 920: 5. Reviews of sections of the Model List: 5.2 Review of core versus complementary listing of medicines". apps.who.int. 2003. Dibukak ing 6 Maret 2017.
- ↑ Beall, Reed (2016). "Patents and the WHO Model List of Essential Medicines (18th Edition): Clarifying the Debate on IP and Access" (PDF). WIPO. Dibukak ing 3 Mèi 2017.
- ↑ Wirtz, VJ; Hogerzeil, HV; Gray, AL; Bigdeli, M; de Joncheere, CP; et al. (28 Januari 2017). "Essential medicines for universal health coverage". The Lancet. 389 (10067): 403–476. doi:10.1016/S0140-6736(16)31599-9. PMID 27832874.
- ↑ a b c "WHO Model Lists of Essential Medicines". World Health Organization. Dibukak ing 17 Januari 2017.
- ↑ Prakash, B; Nadig, P; Nayak, A (2016). "Rational Prescription for a Dermatologist". Indian Journal of Dermatology. 61 (1): 32–8. doi:10.4103/0019-5154.174017. PMC 4763692. PMID 26955092.
- ↑ "WHO Model List of Essential Medicines for Children 5th List" (PDF). who.int. World Health Organization. August 2015. Dibukak ing 17 Januari 2017.
- ↑ Rose, K; Anker, JNVd (2010). Guide to Paediatric Drug Development and Clinical Research (ing basa Inggris). Karger Medical and Scientific Publishers. kc. 42. ISBN 9783805593625.
- ↑ Seyberth, HW; Rane, A; Schwab, M (2011). Pediatric Clinical Pharmacology (ing basa Inggris). Springer Science & Business Media. kc. 358. ISBN 9783642201950.
- ↑ Kalle, H (9 Fèbruari 2017). "Essential Medicines for Children". Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.661. PMID 28182281.
Wacan liyané
[besut | besut sumber]- WHO Model Formulary 2008 (PDF). World Health Organization. 2009. ISBN 9789241547659.
- The selection and use of essential medicines: Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children) (PDF). WHO. 2015. ISBN 9789240694941.